Author
Listed:
- Linnea Z. Drexhage
(The University of Oxford)
- Shengpan Zhang
(The University of Oxford)
- Maeva Dupont
(The University of Oxford
Immunocore Ltd.)
- Franziska Ragaller
(Karolinska Institutet)
- Ellen Sjule
(Karolinska Institutet)
- Jose Cabezas-Caballero
(The University of Oxford)
- Lachlan P. Deimel
(The University of Oxford)
- Helen Robertson
(The University of Oxford)
- Rebecca A. Russell
(The University of Oxford
SpyBiotech Ltd.; 7600 Quorum, Oxford Business Park North)
- Omer Dushek
(The University of Oxford)
- Erdinc Sezgin
(Karolinska Institutet)
- Niloofar Karaji
(The University of Oxford
Oxford Biomedica plc.; Windrush Court, Transport Way)
- Quentin J. Sattentau
(The University of Oxford
Max Delbrück Center for Molecular Medicine in the Helmholtz Association; Berlin-Buch
Charité Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine)
Abstract
Efferocytic clearance of apoptotic cells in general, and T cells in particular, is required for tissue and immune homeostasis. Transmembrane mucins are extended glycoproteins highly expressed in the cell glycocalyx that function as a barrier to phagocytosis. Whether and how mucins may be regulated during cell death to facilitate efferocytic corpse clearance is not well understood. Here we show that normal and transformed human T cells express a subset of mucins which are rapidly and selectively removed from the cell surface during apoptosis. This process is mediated by the ADAM10 sheddase, the activity of which is associated with XKR8-catalyzed flipping of phosphatidylserine to the outer leaflet of the plasma membrane. Mucin clearance enhances uptake of apoptotic T cells by macrophages, confirming mucins as an enzymatically-modulatable barrier to efferocytosis. Together these findings demonstrate a glycocalyx regulatory pathway with implications for therapeutic intervention in the clearance of normal and transformed apoptotic T cells.
Suggested Citation
Linnea Z. Drexhage & Shengpan Zhang & Maeva Dupont & Franziska Ragaller & Ellen Sjule & Jose Cabezas-Caballero & Lachlan P. Deimel & Helen Robertson & Rebecca A. Russell & Omer Dushek & Erdinc Sezgin , 2024.
"Apoptosis-mediated ADAM10 activation removes a mucin barrier promoting T cell efferocytosis,"
Nature Communications, Nature, vol. 15(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-023-44619-8
DOI: 10.1038/s41467-023-44619-8
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-023-44619-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.